Paediatrics 5 – Oncology, Hematology, Immunology

• Paediatric oncology:  diagnostics and therapy of the entire spectrum of malignant and benign tumours with typical onset in childhood and adolescence
• Paediatric haematology:  Diagnostics and therapy of all benign and malignant disorders of the blood - i.e., leukaemia, lymphoma, anaemia
• Paediatric haemostaseology: Diagnostics and therapy of blood-clotting disorders in children and adolescents - i.e., haemophilia, thromboses
• Paediatric immunology: Diagnostics and therapy of congenital and acquired immune defects - i.e., antibody deficiency syndromes, HIV infection

• Paediatric-oncological unit (16 beds)
• Paediatric-oncological outpatient clinic and day clinic (five beds)
• International Reference Centre for Osteo- and Soft Tissue Sarcomas (COSS/CWS)
• Special haematology lab
• Psycho-social care
• Model project HOPPS (Häusliche Onkologische Pädiatrische Pflege Stuttgart – Paediatric Oncological Home Care Stuttgart)
• Apartments for parents in direct proximity to the clinic

• Reference Centre for sarcomas of the bones and soft tissue
• Autological stem-cell apheresis and therapy
• Innovative drug therapy in the context of the European ITCC Consortium

This clinic is the headquarters of the co-operative soft-tissue sarcoma study group CWS and the co-operative osteo-sarcoma study group COSS, two renowned International research associations which (in co-operation with European and U.S.-based partners) conduct clinical studies in young people with sarcomas (tumours of  connective and supporting tissues). The COSS and CWS therapy protocols define the treatment standard now valid for Germany and the neighbouring countries. Another Working group within this department conducts research on rare childhood-onset tumours. At the Molecular Biology Lab, genetic mutations that occur in the progression of paediatric cancer cases are examined. In May 2009, this department hosted the 22nd Annual Conference of the European Society for Musculoskeletal Oncology (EMSOS). The Medical Director is the Vice President of EMSOS and a member of the Executive Board of the Paediatric Oncology and Haematology Society.

• Centre for paediatric haemato-oncological care in accordance with the G-BA Agreement on Paediatric Oncology
• Treatment of all types of cancer in the context of  therapy-enhancement protocols set forth by the Paediatric Oncology and Haematology Society subject to QA measures
• Interdisciplinary paediatric-oncological tumour conferences